The defendants named in the lawsuit include Dr Reddy’s Laboratories Limited, Genpharm, Interpharm, Mylan Pharmaceuticals, Ranbaxy Laboratories, Sun India Pharmaceutical Industries, and related companies and subsidiaries thereof. The Namenda patent expires in April 2010. Forest has applied for patent term extension which, if granted, would extend the patent until September 2013.